Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 1-9

  Windhagen, A ^a   E Anderson, D ^a   Carrizosa, A ^a   Balashov, K ^a   L Weiner, H ^a   A Hafler, D ^a  

^a Center for Neurologic Diseases   (United States)

Author keywords

Autoimmunity; Cytokine; IFN ; IL 4; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MYELIN BASIC PROTEIN;

ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CROSS REACTION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL DIVISION; CELLS, CULTURED; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; T-LYMPHOCYTES;

EID: 0032476640     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00086-1     Document Type: Article

References (44)

1. Allegretta M., Nicklas J.A.et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:1990;718.
2. Balachov K., Smith D.et al. Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U.S.A. 94:1996;599-603.
3. Brod S., Benjamin D.et al. Restricted T cell expression of IL-2/IFN mRNA in human inflammatory disease. J. Immunol. 147:1991;810-815.
4. Chen Y., Kuchroo V.et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
5. Chou F., Chou C.et al. Basis of microheterogeneity of myelin basic protein. J. Biol. Chem. 251:1976;2671-2679.
6. Constant S., Pfeiffer C.et al. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1995;1591-1596.
7. Correale J., Gilmore W.et al. Patterns of cyotkine secretion by autoreactive PLP specific T cell clones during the course of MS. J. Immunol. 154:1995;2959-2968.
8. Cuzner M.L., Hayes G.M.et al. The nature of inflammatory components during demyelination in multiple sclerosis. J. Neuroimmunol. 20:1988;203-209.
9. Evavold B., Sloan-Lancaster J.et al. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today. 14:1993;602-609.
10. Evavold B., Sloan-Lancaster J.et al. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:1993;3131-3140.
11. Hafler D., Weiner H. T cells in multiple sclerosis and inflammatory central nervous system disease. Immunol. Rev. 100:1987;307-333.
12. Hermans G., Stinissen P.et al. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann. Neurol. 42:1997;18.
13. Hofman F.M., von Hanwehr R.I.et al. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136:1986;3239-3245.
14. Hofman F.M., Hinton D.R.et al. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612.
15. Hosken N.A., Shibuya K.et al. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1995;1579-1584.
16. Hsieh C., Macatonia S.E.et al. Development of Th1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science. 260:1993;547-549.
17. Jeannin P., Delneste Y.et al. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 156:1996;3159-3165.
18. Kuchroo V.J., Martin C.A.et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
19. Lehmann P., Forsthuber T.et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
20. Leonard J., Waldburger K.et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
21. Macatonia S.E., Doherty T.M.et al. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150:1993;3755-3765.
22. Manetti R., Parronchi P.et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1993;1199-1204.
23. Markovic-Plese S., Fukaura H.et al. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:1995;982-992.
24. Martin R., Howell M.D.et al. A myelin basic protein peptide is recognized by cytotoxic T cells in the content of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:1991;19-24.
25. McFarlin D., McFarland H. Multiple sclerosis. New. Engl. J. Med. 307:1982;1183.
26. Meyaard L., Hovenkamp E.et al. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156:1996;2776-2782.
27. Monteiro J., Batliwalla F.et al. Shortened telomeres in clonally expanded CD28- CD8+ T cells imply a replicative history which is distinct from their CD28+ CD8+ counterparts. J. Immunol. 156:1996;3587-3590.
28. Ota K., Matsui M.et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
29. Panitch H.S., Hirsch R.L.et al. Exacerbations of multiple sclerosis in patients treated with γ-IFN. Lancet. 1:1987;893.
30. Paty D., Li D. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology. 43:1993;655-661.
31. Powrie F.et al. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;3043-3049.
32. Pette M., Pette D.F.et al. Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology. 49:1997;385.
33. Reiner S., Wang Z.et al. Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science. 259:1993;1457-1460.
34. Rieckmann P., Albrecht M.et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
35. Romagnani S. Lymphokine production by Human T Cells in disease states. Ann. Rev. Immunol. 12:1994;227-257.
36. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497.
37. Voskul R., Martin R.et al. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity. 15:1993;137-143.
38. Waksman, B., Reynolds, W., 1984. Multiple sclerosis as a disease of immune regulation. Proceedings of the Society of Experimental Biological Medicine 175, p. 282.
39. Wang L., Goillot E.et al. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol. 159:1994;152-169.
40. Windhagen A., Newcombe J.et al. Expression of IL-12 and B7 costimulatory molecules in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
41. Windhagen A., Scholz C.et al. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:1995;373-380.
42. Windhagen A., Anderson D.et al. IL-12 induces human T cells secreting IL-10 with IFN-γ J. Immunol. 157:1996;1127-1131.
43. Wucherpfennig K., Strominger J. Molecular Mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
44. Zhang J., Markovic S.et al. Increased frequency of Interleukin 2-responsive T cells specific for Myelin Basic Protein and Proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.